A Post-Marketing Surveillance Study on NesinaAct® Tablet Use Among Type 2 Diabetes Mellitus Participants in Korea

Clinical trial NCT04980014 · COMPLETED

Trial details

NCT number: NCT04980014
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Type 2 Diabetes Mellitus

Start date: 2015-10-02
Primary completion: 2019-08-30
Enrollment: 730

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.